Corbus Pharmaceuticals Holdings, Inc. (CRBP) Financials

CRBP Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 144.5 million 18.1 million
Dec. 31, 2025 168.2 million 20.7 million
Sept. 30, 2025 109.5 million 17.4 million
June 30, 2025 125.1 million 14.1 million

CRBP Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -25.6 million 1.9 million
Dec. 31, 2025 -15.9 million 1.4 million
Sept. 30, 2025 -15.6 million 1.6 million
June 30, 2025 -16.6 million 1.6 million

CRBP Net Income

No data available :(

CRBP Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 138.6 million - 1.2 million
Dec. 31, 2025 163.9 million - 1.6 million
Sept. 30, 2025 104.0 million - 2.0 million
June 30, 2025 116.6 million - 2.5 million

CRBP Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 1870
Dec. 31, 2025 13.3 million
Sept. 30, 2025 12.3 million
June 30, 2025 12.2 million

CRBP Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 6000 19.8 million 4.4 million -49000
Dec. 31, 2025 7000 18.4 million 3.6 million -
Sept. 30, 2025 - 20.9 million 3.6 million -
June 30, 2025 - 15.2 million 4.0 million -

CRBP Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 49000
Dec. 31, 2025 - 49000
Sept. 30, 2025 - -
June 30, 2025 - 100000

CRBP

Price: $8.26

52 week price:
6.72
20.56

Earnings Per Share: -5.74 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 1.8 million

Ebitda: -6.8 million

Market Capitalization: 94.8 million

Links: